Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI

1 Jan 2022

Abstract excerpt

Introduction: Ethnoracial differences in cerebrospinal fluid (CSF; amyloid beta 42 [Aβ42], total tau [t-tau], phosphorylated tau 181 [p-tau181], and plasma (p-tau181, neurofilament light [NfL]) biomarkers of Alzheimer's disease (AD) are incompletely understood. Methods: We performed cross-sectional analyses with and without adjustment for covariates comparing baseline CSF (Aβ42, t-tau, p-tau181) and plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Health, Environment, Cognitive Aging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35510092
DOI: 10.1002/dad2.12315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNIPMID 35510092Read ↗

Comparison of plasma and CSF biomarkers across ethnoracial groups in ADNISemantic proximity Read ↗

Alzheimer's disease plasma biomarkers and physical functioning in a diverse sample of adultsSemantic proximity Read ↗

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read ↗

Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individualsSemantic proximity Read ↗

Neurodegenerative Plasma Biomarkers for Prediction of Hippocampal Atrophy in Older Adults with Suspected Alzheimer’s Disease in Kinshasa, Democratic Republic of CongoSemantic proximity Read ↗

The association of blood-based biomarkers of neuropathology with cognitive performance and incident dementia in a diverse, nationally-representative sample of US adultsSemantic proximity Read ↗

Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognitionSemantic proximity Read ↗

Generalizability of tau and amyloid plasma biomarkers in Alzheimer's disease cohorts of diverse genetic ancestriesSemantic proximity Read ↗

Assessment of Racial Disparities in Biomarkers for Alzheimer DiseaseSemantic proximity Read ↗

Alzheimer Disease Plasma Biomarkers in the Mid-Western AmishSemantic proximity Read ↗

The Bio‐Hermes Study: Biomarker database developed to investigate blood‐based and digital biomarkers in community‐based, diverse populations clinically screened for Alzheimer's diseaseSemantic proximity Read ↗

Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volumeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.